Therapeutic touch in psilocybin therapy: often valuable, but only with clear boundaries and consent

There is a new scientific article that investigates how participants experience therapeutic touch during psilocybin-assisted therapy.

In it, we discuss:

The authors wanted to better understand what touch means to participants during a psychedelic session. In practice, supportive touch is sometimes used to calm, ground, or provide support, but its role is still poorly defined and is ethically sensitive. Therefore, the researchers looked not only at potential benefits but also at risks and boundaries.

The true focus of this article is not on symptom scores or the effectiveness of psilocybin itself, but on the subjective experience of touch within the therapeutic setting. For the qualitative analysis, 39 semi-structured interviews with 18 participants were examined. In addition, there were descriptive survey data from 72 participants regarding how important they considered therapeutic touch within psychedelic-assisted therapy.

The results show that most participants appreciated the opportunity for touch, especially after experiencing it themselves. Touch was described as something that could strengthen emotional connection, provide support during intense moments, and sometimes help to better regulate the experience. At the same time, not everyone attributed the same meaning to touch. Some participants may have found it distracting or uncomfortable, which, according to the authors, demonstrates that a tailored approach is necessary.

The full article also reveals that acceptance of touch was strongly associated with trust in the therapists and with a careful consent process. The authors even emphasize that a good therapeutic alliance was a prerequisite for touch rather than a consequence of it. In the broader survey, the average rating for the importance of touch was 75.38 out of 100, but the spread was wide, indicating that touch is valuable to many people, but certainly not to everyone in the same way.

It is important to note, however, that this is a qualitative study within a specific psilocybin trial using a minimalist and client-driven touch protocol. Therefore, this article does not prove that touch in itself is an active therapeutic intervention. On the contrary, the authors warn that more intensive forms of physical contact may entail additional risks and should only be considered with a high degree of transparency, training, and monitoring.

In one sentence: this article shows that therapeutic touch during psilocybin therapy can be supportive and regulating for many participants, but only appears safe and appropriate when consent, trust, and individual attunement are central.